 - Anti-HSV antivirals: Subjects whose physicians determine that anti-HSV antiviral therapy such as acyclovir, ganciclovir, foscarnet, etc. cannot be safely discontinued from 2 days prior to the injection to 28 days following the injection should not be in the study. 